| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/11/2011 | CN102056615A Compositions of peptides and processes of preparation thereof |
| 05/11/2011 | CN102056600A Combination therapy for the treatment of bacterial infections |
| 05/11/2011 | CN102056593A Nasal formulations of insulin |
| 05/11/2011 | CN102051370A Clam cathepsin B gene, encoding protein and application thereof |
| 05/11/2011 | CN102051363A Clam ferroprotein gene as well as coding protein and application of in vitro recombinant expression product of same |
| 05/11/2011 | CN102051348A Humanized recombinant uricase and mutant thereof |
| 05/11/2011 | CN102050873A Analgesic active mutants of scorpion analgesic and antibiotic active peptide and acquiring method thereof |
| 05/11/2011 | CN102050869A Vancomycin compound |
| 05/11/2011 | CN102050867A Tetrapeptide analog, preparation method and application thereof |
| 05/11/2011 | CN102049048A Method of treatment or prophylaxis |
| 05/11/2011 | CN102049042A Novel oral compound capsule preparation for treating diabetes and obesity |
| 05/11/2011 | CN102049041A Use of IL-4 in preparing medicine for curing serious hepatitis |
| 05/11/2011 | CN102049040A Artificial surface-active substance mixed liquid as well as preparation and application thereof |
| 05/11/2011 | CN102049039A Application of p65 in preparation of medicament for up-regulating SIRT1 expression |
| 05/11/2011 | CN102049038A Application of gelatinase A inhibitory polypeptide modifier |
| 05/11/2011 | CN102049037A Application of ocean collagen peptide in process of preparing diabetes wound healing medicaments and foods |
| 05/11/2011 | CN102049036A Application of oceanic collagen peptide in preparation of drunkenness preventing medicaments, health-care food or food |
| 05/11/2011 | CN102049035A Starch polysaccharide-iron compound preparation |
| 05/11/2011 | CN102049034A Hoof nail polypeptide preparation for promoting tissue repair and preparation method thereof |
| 05/11/2011 | CN102048761A Preparation method of enteric coated tablet with leech as raw material |
| 05/11/2011 | CN102048757A Method for constructing lung tumor experimental animal model |
| 05/11/2011 | CN102048699A Preparation method for sustained release microsphere of injection triptorelin acetate |
| 05/11/2011 | CN101619315B Functional gene Rdr-lec sequence of rana chensinensis lectin sample, construction method, amino acid sequence thereof and application thereof |
| 05/11/2011 | CN101570760B Recombinant mouse beta-alexin 3 polypeptide, preparation and use thereof |
| 05/11/2011 | CN101503459B Bloody noun antibacterial peptide temporin-Lb, genes thereof and use in pharmacy |
| 05/11/2011 | CN101381404B Targeting tumor protein KCT-W2, preparation method and application |
| 05/11/2011 | CN101366944B Uses of MRPINK in restraining liveness of Macrobracium rosenbergii spermatozoon |
| 05/11/2011 | CN101361969B Therapeutic hepatitis b vaccine and preparation method and use thereof |
| 05/11/2011 | CN101314616B Hemorrhagic bacillus coli of intestine 0157:H7 shiga toxin IIB epitope peptide and uses thereof |
| 05/11/2011 | CN101306196B Biodegradable nano-particles bonded with hemoglobin and production method thereof |
| 05/11/2011 | CN101302246B Melanin cortical hormone receptor heptapeptide excitant, preparation and use thereof |
| 05/11/2011 | CN101195799B SOD distillate spirits and manufacturing method thereof |
| 05/11/2011 | CN101153055B Novel peptide with angiotonin transferase restraining liveness and method of producing the same |
| 05/11/2011 | CN101061134B Novel topical application agents against mimic and age-related wrinkles |
| 05/10/2011 | US7939667 Hepatitis C inhibitor compounds |
| 05/10/2011 | US7939654 Platelet derived growth factor (PDGF) nucleic acid ligand complexes |
| 05/10/2011 | US7939650 For stimulating release of tumor necrosis factor and/or cellular prolifefration/differentiation of chondrocytes by contacting blood w/polypeptide; diagnosis cancer |
| 05/10/2011 | US7939647 Insect desiccation resistance genes and uses thereof |
| 05/10/2011 | US7939646 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 05/10/2011 | US7939640 Antibodies that bind B7L-1 |
| 05/10/2011 | US7939639 Functional role of adrenomedullin (AM) and the gene related product (PAMP) in human pathology and physiology |
| 05/10/2011 | US7939635 Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy |
| 05/10/2011 | US7939632 Proteolytically cleavable fusion proteins with high molar specific activity |
| 05/10/2011 | US7939631 APO-2 receptor polypeptides |
| 05/10/2011 | US7939628 Deprotecting amino acid linked to solid phase resin by admixing with solution in transparent vessel while irradiating with microwaves, coupling/activating/hybridizing amino acids, then cleaving |
| 05/10/2011 | US7939627 Peptides comprising an epitope of the wilms tumor gene product |
| 05/10/2011 | US7939626 Chemoselective ligation |
| 05/10/2011 | US7939625 Somatostatin analogues |
| 05/10/2011 | US7939624 Peptide able to break the m-p53/p63, m-p53/p73 and m-p53/respective isoform proteins complex formed in the tumor cells and uses thereof in the pharmacological field |
| 05/10/2011 | US7939623 Composition containing flavan compound |
| 05/10/2011 | US7939504 Method of treating skin ulcers with vectors encoding hepatocyte growth factor |
| 05/10/2011 | US7939503 Nucleotide sequences coding six transmembrane epithelial antigen of the prostate (STEAP)-1) for use as tool in diagnosis, prevention and treatment of cell proliferative disorders; RNA intereference |
| 05/10/2011 | US7939501 prevent eye irritation and discomfort; contains cationic polymeric preservative and buffer; amphipathic peptides effective against both gram-positive and gram-negative bacteria, and as antideposit agent for reducing cationic preservatives deposition |
| 05/10/2011 | US7939500 Antifungal paints and coatings |
| 05/10/2011 | US7939499 Method for increasing cardiac mass and performance |
| 05/10/2011 | US7939498 Cyclic peptides for preserving or enhancing the function of an organ allograft |
| 05/10/2011 | US7939497 Preventing or treating a disease or disorder associated with Slit2 mediated angiogenesis in a subject by use of pharmaceutical composition comprising a substance that reduces or enhances Slit2-Slit2 receptor interaction |
| 05/10/2011 | US7939496 Modified human growth horomone polypeptides and their uses |
| 05/10/2011 | US7939495 Method for improving skin conditions |
| 05/10/2011 | US7939494 Method for administering GLP-1 molecules |
| 05/10/2011 | US7939493 Peptide inhibitors of protein kinase C |
| 05/10/2011 | US7939492 Factor C for treating gram-negative bacterial infection |
| 05/10/2011 | US7939491 Method for reducing the likelihood of implantation failure during assisted reproduction in a subject |
| 05/10/2011 | US7939490 TWEAK as a therapeutic target for treating central nervous system diseases associated with cerebral edema and cell death |
| 05/10/2011 | US7939302 Process for producing dipeptides |
| 05/10/2011 | US7939297 Mammalian cytokines; related reagents and methods |
| 05/10/2011 | US7939295 Methods for reducing immunogenicity of polypeptides |
| 05/10/2011 | US7939292 Modified heparinase III and methods of sequencing therewith |
| 05/10/2011 | US7939274 Prostate cancer-related compositions, methods and kits based on DNA macroarray proteomics platforms |
| 05/10/2011 | US7939250 Vitamin K epoxide recycling polypeptide VKORC1, a therapeutic target of coumarin and their derivatives |
| 05/10/2011 | US7939114 Preparation, process and a regenerative method and technique for prevention, treatment and glycemic control of diabetes mellitus |
| 05/10/2011 | US7939106 Surface stabilized fenofibrate particles have a particle size of 10 mu m or less; phospholipid surface modifier; dispersed in a bulking/ releasing matrix |
| 05/10/2011 | US7939105 Rapidly dispersing solid dry therapeutic dosage |
| 05/10/2011 | US7939099 Sustained improver of muscular fatigue |
| 05/10/2011 | US7939098 Compositions and method for transmucosal drug delivery and cryoprotection |
| 05/10/2011 | US7939080 HER-2 binding antagonists |
| 05/10/2011 | US7939079 Helicobacter species and cultivation thereof |
| 05/10/2011 | US7939078 Methods of enhancing the immune response to autoantigens in mucosal associated lymphatic tissue |
| 05/10/2011 | US7939073 Immunotherapy of B-cell malignancies using anti-CD22 antibodies |
| 05/10/2011 | US7939071 Artery- and vein-specific proteins and uses therefor |
| 05/10/2011 | US7939068 Antagonizing signal transduction in dorsal root ganglion cells in a subject with IL-31 antagonists |
| 05/10/2011 | US7939067 Purified recombinant batroxobin with high specific activity |
| 05/10/2011 | US7939066 Methods and compositions for the inhibition of growth of infectious Aspergillus fumigatus and other mycotic organisms in the gut of mammalian and avian species |
| 05/10/2011 | US7939065 Chondroitin sulfate synthesis promoter |
| 05/10/2011 | US7939064 Phospholipase(s) and use(s) thereof |
| 05/10/2011 | US7939061 Cell and enzyme compositions for modulating bile acids, cholesterol and triglycerides |
| 05/10/2011 | US7939058 Interleukin-12 (IL-12) used after chemotherapy, radiotherapy or viral infection to yield hematopoietic recovery, for bone marrow preservation or recovery |
| 05/10/2011 | US7939057 Methods and compositions for modulating the mobilization of stem cells |
| 05/10/2011 | US7939056 Interleukin-10 compositions for the treatment of adenocarcinomas |
| 05/10/2011 | US7939052 Method of measuring the biological activity of an urotensin II receptor |
| 05/10/2011 | US7938641 Extrusion die |
| 05/10/2011 | CA2503594C Positional isomers of peg ifn alpha 2a |
| 05/10/2011 | CA2483105C Autoimmune conditions and nadph oxidase defects |
| 05/10/2011 | CA2459754C Vaccinia virus mva-e3l-knock-out-mutants and use thereof |
| 05/10/2011 | CA2457057C Compositions and methods for treating neurodegenerative diseases |
| 05/10/2011 | CA2439170C Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors |
| 05/10/2011 | CA2437535C Polynucleotide useful for modulating cancer cell proliferation |
| 05/10/2011 | CA2431890C Lipid microparticles by cryogenic micronization |
| 05/10/2011 | CA2419385C Saratin for inhibiting platelet adhesion to collagen |
| 05/10/2011 | CA2416293C Somatostatin analogues |